Scarica l'app Stockscreener
32.29
1.06%
0.34
Dopo l'orario di chiusura:
31.50
-0.79
-2.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$31.95
Aprire:
$32.22
Volume 24 ore:
3.06M
Relative Volume:
0.65
Capitalizzazione di mercato:
$14.00B
Reddito:
$2.27B
Utile/perdita netta:
$1.15B
Rapporto P/E:
12.66
EPS:
2.55
Flusso di cassa netto:
$2.80B
1 W Prestazione:
+4.06%
1M Prestazione:
-1.46%
6M Prestazione:
+15.86%
1 anno Prestazione:
+14.42%
Intervallo 1D:
$31.77
$32.32
Intervallo di 1 settimana:
$30.04
$32.32
Portata 52W:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.29 | 14.00B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
495.83 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.06 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
606.39 | 36.98B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
240.01 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
242.75 | 26.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Aviva PLC Purchases 214,946 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Legal & General Group Plc Decreases Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Fmr LLC - MarketBeat
APG Asset Management N.V. Grows Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management US Inc. Takes $201,000 Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
JPMorgan Chase & Co. Purchases 105,824 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
ADAR1 Capital Management LLC Sells 1,046,703 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Franklin Resources Inc. Sells 921,034 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma modifies acquisition agreement By Investing.com - Investing.com South Africa
Royalty Pharma modifies acquisition agreement - Investing.com
ExodusPoint Capital Management LP Invests $3.66 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Prudential PLC - MarketBeat
Headlands Technologies LLC Has $115,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Geode Capital Management LLC Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know - Yahoo Finance
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Position Cut by Rhenman & Partners Asset Management AB - MarketBeat
Integrated Quantitative Investments LLC Buys New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Enters Oversold Territory - Nasdaq
Russell Investments Group Ltd. Purchases 449,551 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Sei Investments Co. Has $2.80 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Appoints Vlad Coric to Board of Directors - citybiz
Royalty Pharma expands board with Biohaven CEO appointment By Investing.com - Investing.com South Africa
Royalty Pharma expands board with Biohaven CEO appointment - Investing.com Australia
Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors - The Manila Times
Biotech Leader Behind $13B Pfizer-Biohaven Deal Takes Strategic Role at Royalty Pharma - Stock Titan
Arrowstreet Capital Limited Partnership Lowers Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Alliancebernstein L.P. - MarketBeat
California Public Employees Retirement System Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Allstate Corp Takes $299,000 Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Pictet Asset Management Holding SA Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Trexquant Investment LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Korea Investment CORP Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Brandywine Global Investment Management LLC Acquires 142,176 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Elo Mutual Pension Insurance Co Buys 11,089 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Is Royalty Pharma Plc (RPRX) the Most Undervalued Healthcare Stock to Buy? - AInvest
Vanguard Group Inc. Has $952.90 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Investment Analysis and Advice - news.stocktradersdaily.com
Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? - MSN
Norges Bank Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):